iodixanol has been researched along with Hepatocellular Carcinoma in 15 studies
iodixanol: dimeric contrast media; structure given in first source
iodixanol : A dimeric, non-ionic, water-soluble, radiographic contrast agent, used particularly in coronary angiography.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purposes of this study were to evaluate the effect of contrast material flow rate (3 mL/sec vs 5 mL/sec) on the detection and visualization of hepatocellular carcinoma (HCC) with MDCT and the safety profile of iodixanol at different injection rates." | 5.12 | Quadruple-phase MDCT of the liver in patients with suspected hepatocellular carcinoma: effect of contrast material flow rate. ( Bellomi, M; Brisbois, D; Catalano, C; Chevallier, P; Dirisamer, A; Dobritz, M; Drouillard, J; Fraioli, F; Hammerstingl, R; Jesus Martinez, M; Marti-Bonmati, L; Montero, FT; Morassut, S; Rummeny, EJ; Schima, W; Vogl, TJ; Westermayer, B, 2006) |
| "We have developed and optimized a rapid iodixanol (OptiPrep)-based gradient centrifugation system to identify, isolate and characterize doxorubicin (DXR)-induced senescent hepatocellular carcinoma (HCC) cells (HepG2 and Huh-7) in vitro." | 3.91 | Isolation of senescent cells by iodixanol (OptiPrep) density gradient-based separation. ( Kovacovicova, K; Vinciguerra, M, 2019) |
| "SRFA allowed for efficient, reliable, and safe ablation of large-volume liver disease." | 1.38 | Stereotactic radiofrequency ablation (SRFA) of liver lesions: technique effectiveness, safety, and interoperator performance. ( Bale, R; Haidu, M; Schullian, P; Widmann, G, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (26.67) | 29.6817 |
| 2010's | 11 (73.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kovacovicova, K | 1 |
| Vinciguerra, M | 1 |
| Albrecht, MH | 1 |
| Vogl, TJ | 2 |
| Wichmann, JL | 1 |
| Martin, SS | 1 |
| Scholtz, JE | 1 |
| Fischer, S | 2 |
| Hammerstingl, RM | 1 |
| Harth, M | 1 |
| Nour-Eldin, NA | 1 |
| Thalhammer, A | 1 |
| Zangos, S | 1 |
| Bauer, RW | 1 |
| Jang, HJ | 1 |
| Kim, TK | 1 |
| Khalili, K | 1 |
| Yazdi, L | 1 |
| Menezes, R | 1 |
| Park, SH | 1 |
| Sherman, M | 1 |
| Vandecaveye, V | 1 |
| Michielsen, K | 1 |
| De Keyzer, F | 1 |
| Laleman, W | 1 |
| Komuta, M | 1 |
| Op de beeck, K | 1 |
| Roskams, T | 1 |
| Nevens, F | 1 |
| Verslype, C | 1 |
| Maleux, G | 1 |
| Rose, SC | 1 |
| Kikolski, SG | 1 |
| Morshedi, MM | 1 |
| Narsinh, KH | 1 |
| Jhaveri, KS | 1 |
| Halankar, J | 1 |
| Aguirre, D | 1 |
| Haider, M | 1 |
| Lockwood, G | 1 |
| Guindi, M | 1 |
| Deschamps, F | 1 |
| Solomon, SB | 1 |
| Thornton, RH | 1 |
| Rao, P | 1 |
| Hakime, A | 1 |
| Kuoch, V | 1 |
| de Baere, T | 1 |
| Kim, HC | 1 |
| Chung, JW | 1 |
| Jae, HJ | 1 |
| Yoon, JH | 1 |
| Lee, JH | 1 |
| Kim, YJ | 1 |
| Lee, HS | 1 |
| Yoon, CJ | 1 |
| Park, JH | 1 |
| Bouvier, A | 1 |
| Ozenne, V | 1 |
| Aubé, C | 1 |
| Boursier, J | 1 |
| Vullierme, MP | 1 |
| Thouveny, F | 1 |
| Farges, O | 1 |
| Vilgrain, V | 1 |
| Widmann, G | 1 |
| Schullian, P | 1 |
| Haidu, M | 1 |
| Bale, R | 1 |
| Golowa, YS | 1 |
| Cynamon, J | 1 |
| Reinus, JF | 1 |
| Kinkhabwala, M | 1 |
| Abrams, M | 1 |
| Jagust, M | 1 |
| Chernyak, V | 1 |
| Kaubisch, A | 1 |
| Bova, V | 1 |
| Miraglia, R | 1 |
| Maruzzelli, L | 1 |
| Vizzini, GB | 1 |
| Luca, A | 1 |
| Schima, W | 1 |
| Hammerstingl, R | 1 |
| Catalano, C | 1 |
| Marti-Bonmati, L | 1 |
| Rummeny, EJ | 1 |
| Montero, FT | 1 |
| Dirisamer, A | 1 |
| Westermayer, B | 1 |
| Bellomi, M | 1 |
| Brisbois, D | 1 |
| Chevallier, P | 1 |
| Dobritz, M | 1 |
| Drouillard, J | 1 |
| Fraioli, F | 1 |
| Jesus Martinez, M | 1 |
| Morassut, S | 1 |
| Christova, T | 1 |
| Templeton, DM | 1 |
| Graham, JM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Interobserver Agreement of Determination of Hepatocellular Carcinoma Feeding Vessels : Multi-Detector CT Angiography With 3D Reconstruction Versus Digital Subtraction Angiography[NCT05304572] | 70 participants (Actual) | Observational | 2022-05-01 | Completed | |||
| Stereotactic Image-Guided Microwave Ablation for Hepatocellular Carcinoma - Does Computer-assistance Broaden Eligibility and Efficacy of Ablative Treatment?[NCT03630068] | 87 participants (Actual) | Observational | 2015-01-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for iodixanol and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Dynamic 4D-CT Angiography for Guiding Transarterial Chemoembolization: Impact on the Reduction of Contrast Material, Operator Radiation Exposure, Catheter Consumption, and Diagnostic Confidence.
Topics: Aged; Aged, 80 and over; Bile Duct Neoplasms; Carcinoma, Hepatocellular; Catheters; Chemoembolizatio | 2018 |
Quadruple-phase MDCT of the liver in patients with suspected hepatocellular carcinoma: effect of contrast material flow rate.
Topics: Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Liver Neoplasms; Male; Middle Aged; Prosp | 2006 |
13 other studies available for iodixanol and Hepatocellular Carcinoma
| Article | Year |
|---|---|
Isolation of senescent cells by iodixanol (OptiPrep) density gradient-based separation.
Topics: Carcinoma, Hepatocellular; Cell Separation; Cellular Senescence; DNA Damage; Doxorubicin; Humans; Li | 2019 |
Characterization of 1-to 2-cm liver nodules detected on hcc surveillance ultrasound according to the criteria of the American Association for the Study of Liver Disease: is quadriphasic CT necessary?
Topics: Adult; Aged; Carcinoma, Hepatocellular; Contrast Media; Female; Humans; Liver Neoplasms; Logistic Mo | 2013 |
Chemoembolization for hepatocellular carcinoma: 1-month response determined with apparent diffusion coefficient is an independent predictor of outcome.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Diffusion | 2014 |
Feasibility of Intraprocedural Transluminal Hepatic and Femoral Artery Blood Pressure Measurements as an Alternative Embolization Safety Endpoint When Antireflux Devices Are Used During Lobar Chemoembolization.
Topics: Aged; Aged, 80 and over; Angiography, Digital Subtraction; Antineoplastic Agents; Blood Pressure; Ca | 2015 |
Intrahepatic bile duct dilatation due to liver metastases from colorectal carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Chi-Square Dist | 2009 |
Computed analysis of three-dimensional cone-beam computed tomography angiography for determination of tumor-feeding vessels during chemoembolization of liver tumor: a pilot study.
Topics: Adult; Aged; Angiography; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Cone-Beam Compu | 2010 |
Caudate lobe hepatocellular carcinoma treated with selective chemoembolization.
Topics: Adult; Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Doxorubicin; | 2010 |
Transarterial chemoembolisation: effect of selectivity on tolerance, tumour response and survival.
Topics: Aged; Biopsy, Needle; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Media; Eth | 2011 |
Stereotactic radiofrequency ablation (SRFA) of liver lesions: technique effectiveness, safety, and interoperator performance.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; Catheter Ablation; Contrast Media; Female | 2012 |
Value of noncontrast CT immediately after transarterial chemoembolization of hepatocellular carcinoma with drug-eluting beads.
Topics: Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Contrast Med | 2012 |
Predictive factors of downstaging of hepatocellular carcinoma beyond the Milan criteria treated with intra-arterial therapies.
Topics: Adult; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Chi-Square Distribution; Contrast | 2013 |
Effect of hypoxia on the binding and subcellular distribution of iron regulatory proteins.
Topics: Animals; Calcium; Carcinoma, Hepatocellular; Cell Fractionation; Cell Line; Endoplasmic Reticulum; H | 2007 |
Isolation of peroxisomes from tissues and cells by differential and density gradient centrifugation.
Topics: Animals; Biomarkers; Carcinoma, Hepatocellular; Cell Fractionation; Cell Line, Tumor; Centrifugation | 2001 |